View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Market Data
July 28, 2016updated 29 Oct 2021 6:20am

M&As this week: Luye Pharma Group Ltd, China Resources Sanjiu Medical

Luye Pharma Group Ltd has announced its acquirement of the entire issued share capital of Acino AG and Acino Supply AG for a purchase consideration of $268.8m.

Luye Pharma Group Ltd has announced its acquirement of the entire issued share capital of Acino AG and Acino Supply AG for a purchase consideration of $268.8m.

The acquisition is expected to be completed in the second half of 2016.

The transaction will allow Luye Pharma to improve its international approach and gain access to boarder therapeutic areas and will help Acino AG to grow in its key market.

China Resources Sanjiu Medical & Pharmaceutical Co. Ltd has announced to acquire Kunming Shenghuo Pharmaceutical for a purchase consideration of $282.67m.

The company will fund the entire costs associated with the acquisitions through its own funds.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena